ZONISADE is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Azurity Phramaceuticals, Inc.. The primary component is Zonisamide.
Product ID | 52652-8001_6db53d1f-51d3-4052-b6d9-1ef1e7431415 |
NDC | 52652-8001 |
Product Type | Human Prescription Drug |
Proprietary Name | ZONISADE |
Generic Name | Zonisamide |
Dosage Form | Suspension |
Route of Administration | ORAL |
Marketing Start Date | 2022-07-15 |
Marketing Category | NDA / |
Application Number | NDA214273 |
Labeler Name | Azurity Phramaceuticals, Inc. |
Substance Name | ZONISAMIDE |
Active Ingredient Strength | 100 mg/5mL |
Pharm Classes | Anti-epileptic Agent [EPC], Carbonic Anhydrase Inhibitors [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], P-Glycoprotein Inhibitors [MoA], Sulfonamides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-07-15 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0185-0193 | Zonisamide | Zonisamide |
0185-0199 | Zonisamide | Zonisamide |
0185-0200 | Zonisamide | Zonisamide |
0378-6725 | Zonisamide | zonisamide |
0378-6726 | Zonisamide | zonisamide |
0378-6727 | Zonisamide | zonisamide |
0615-1379 | Zonisamide | zonisamide |
0615-8266 | zonisamide | zonisamide |
21695-155 | ZONISAMIDE | ZONISAMIDE |
21695-654 | ZONISAMIDE | ZONISAMIDE |
29300-428 | Zonisamide | Zonisamide |
29300-429 | Zonisamide | Zonisamide |
29300-430 | Zonisamide | Zonisamide |
31722-228 | Zonisamide | Zonisamide |
33261-843 | ZONISAMIDE | ZONISAMIDE |
35356-143 | ZONISAMIDE | ZONISAMIDE |
43063-575 | Zonisamide | zonisamide |
43063-932 | Zonisamide | Zonisamide |
50090-2174 | Zonisamide | Zonisamide |
50268-816 | Zonisamide | Zonisamide |
51079-768 | Zonisamide | zonisamide |
51407-137 | Zonisamide | Zonisamide |
51407-138 | Zonisamide | Zonisamide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZONISADE 90400843 not registered Live/Pending |
Eton Pharmaceuticals, Inc. 2020-12-22 |